The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
Incline Peps does not provide dosing, preparation, administration, treatment, clinical or personal-use guidance for any product.
"It really depends on their metabolism," Dr
Current dual agonists under investigation also include efinopegdutide and cotadutide
Mol Metab 2018;18:314.ArticlePubMedPMC 53
The BMI threshold of 23 is well below the industry standard of 27-30
